Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 60
Filter
1.
Microb Pathog ; 128: 184-194, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30611768

ABSTRACT

Hepatocellular carcinoma (HCC) is a cancer which occurs in liver and severity of this cancer makes it the sixth most prevalent cancer and second leading cause of death among all cancers. The load of hepatitis-B virus (HBV) in serum is one of the important risk factors for the HCC. Several other factors also contribute to the HBV associated malignant hepatoma (HCC) i.e. HBV mutation, integration and condition of the host. Transformation of the liver to HBV-associated HCC usually accompanies long-run symptoms i.e. inflammation and cirrhosis of the liver and infective agent load could be a vigorous prognosticator for each incidence and progression of this carcinoma. One of the prominent factors i.e. HBV X supermolecule (HBx) interferes with many signal pathways that are related to the proliferation and apoptosis of hepatic cells. Besides, HBx C-terminal truncation is also responsible for HCC. Longtime HBV infection causes risk of HCC; thus most of the study related to HBV (85%) is limited to HBV endemic regions. In this review, we have outlined the molecular mechanisms that come from other than HBV endemic places which can be innovative approaches to treat HCC.


Subject(s)
Carcinoma, Hepatocellular/virology , Hepatitis B virus/genetics , Hepatitis B virus/pathogenicity , Liver Neoplasms/virology , Angiogenesis Inhibitors/pharmacology , Antiviral Agents/pharmacology , Apoptosis , Biomarkers/blood , Biomarkers/urine , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/immunology , Carcinoma, Hepatocellular/pathology , Cell Proliferation , Drug Delivery Systems , ErbB Receptors/drug effects , Hepatitis B/complications , Hepatitis B/virology , Hepatitis B Surface Antigens/physiology , Hepatitis B virus/drug effects , Hepatitis B virus/growth & development , Hepatocytes/pathology , Hepatocytes/virology , Humans , Inflammation , Life Cycle Stages , Liver , Liver Cirrhosis/pathology , Liver Neoplasms/epidemiology , Liver Neoplasms/immunology , Liver Neoplasms/pathology , MicroRNAs/metabolism , Mutation , Nucleocapsid/metabolism , Oncogene Proteins, Viral/metabolism , Pathology, Molecular , Risk Factors , Signal Transduction , Trans-Activators/metabolism , Viral Load , Viral Regulatory and Accessory Proteins
2.
Med Sci Monit ; 23: 1385-1393, 2017 Mar 21.
Article in English | MEDLINE | ID: mdl-28321112

ABSTRACT

BACKGROUND The aim of this study was to characterize the expression and secretion of hepatitis B surface-antigen (HBsAg) in the hepatocytes of hepatitis B virus (HBV)-infected patients at different phases of infection; as such, the association of intrahepatic HBsAg expression with virological markers and the histological characteristics were analyzed. MATERIAL AND METHODS 302 chronic HBV infection patients who had not received antiviral therapy were stratified by HBeAg status. The proportion of HBsAg-positive cells was used as an indicator for HBsAg expression level. RESULTS In HBeAg-positive patients, there was a significant correlation between serum HBsAg and serum HBV DNA levels (r=0.569, p<0.001). Intrahepatic HBsAg expression and serum HBsAg level in HBeAg-positive patients were higher than those in HBeAg-negative patients (p=0.002 and p<0.001, respectively). A significant correlation between serum HBsAg level and intrahepatic HBsAg expression was found in HBeAg-negative patients (r=0.377, p<0.001), but not in HBeAg-positive patients (r=0.051, p=0.557). Very interestingly, the correlation between serum HBsAg level and HBsAg expression in hepatocytes gradually increased along with disease progression through the immune-tolerant, immune-clearance, inactive, and recovery phases of HBV infection (r=-0.184, 0.068, 0.492, and 0.575; and p=0,238, 0,722, 0.012, and 0.002, respectively). CONCLUSIONS Different mechanisms may be involved in HBsAg synthesis and secretion in different phases of chronic HBV infection.


Subject(s)
Hepatitis B Surface Antigens/biosynthesis , Hepatitis B Surface Antigens/physiology , Hepatitis B e Antigens/physiology , Adult , Biomarkers/blood , DNA, Viral/blood , Female , Hepatitis B Surface Antigens/blood , Hepatitis B e Antigens/blood , Hepatitis B virus/genetics , Hepatitis B, Chronic/blood , Hepatocytes/pathology , Humans , Liver/pathology , Male , Middle Aged , Viral Load
3.
Trends Microbiol ; 24(8): 597-599, 2016 08.
Article in English | MEDLINE | ID: mdl-27345260

ABSTRACT

Initial hepatitis B virus (HBV) attachment occurs via heparan sulfate proteoglycans (HSPGs), which then trigger receptor-mediated internalization. Although HSPGs express in many tissues, HBV is destined for hepatotropic infection. A recent paper by Seitz et al. proposed that the slow viral maturation process plays a critical role in liver-specific distribution.


Subject(s)
Hepatitis B virus/physiology , Hepatitis B virus/pathogenicity , Virus Internalization , Heparan Sulfate Proteoglycans , Hepatitis B Surface Antigens/physiology , Hepatitis B virus/growth & development , Humans , Protein Precursors/physiology , Virus Attachment
4.
Hepatology ; 63(5): 1592-607, 2016 May.
Article in English | MEDLINE | ID: mdl-26892811

ABSTRACT

UNLABELLED: Chronic hepatitis B virus (HBV) infection remains the most common risk factor for hepatocellular carcinoma (HCC). Efficient suppression of HBV viremia and necroinflammation as a result of nucleos(t)ide analogue treatment is able to reduce HCC incidence; nevertheless, hepatocarcinogenesis can occur in the absence of active hepatitis, correlating with high HBV surface antigen (HBsAg) levels. Nuclear factor κB (NF-κB) is a central player in chronic inflammation and HCC development. However, in the absence of severe chronic inflammation, the role of NF-κB signaling in HCC development remains elusive. As a model of hepatocarcinogenesis driven by accumulation of HBV envelope polypeptides, HBsAg transgenic mice, which show no HBV-specific immune response, were crossed to animals with hepatocyte-specific inhibition of canonical NF-κB signaling. We detected prolonged, severe endoplasmic reticulum stress already at 20 weeks of age in NF-κB-deficient hepatocytes of HBsAg-expressing mice. The unfolded protein response regulator binding immunoglobulin protein/78-kDa glucose-regulated protein was down-regulated, activating transcription factor 6, and eIF2α were activated with subsequent overexpression of CCAAT/enhancer binding protein homologous protein. Notably, immune cell infiltrates and liver transaminases were unchanged. However, as a result of this increased cellular stress, insufficient hepatocyte proliferation due to G1 /S-phase cell cycle arrest with overexpression of p27 and emergence of ductular reactions was detected. This culminated in increased DNA damage already at 20 weeks of age and finally led to 100% HCC incidence due to NF-κB inhibition. CONCLUSION: The role of canonical NF-κB signaling in HCC development depends on the mode of liver damage; in the case of HBsAg-driven hepatocarcinogenesis, NF-κB in hepatocytes acts as a critical tumor suppressor by augmenting the endoplasmic reticulum stress response.


Subject(s)
Carcinoma, Hepatocellular/prevention & control , Hepatitis B Surface Antigens/physiology , Hepatocytes/metabolism , Liver Neoplasms/prevention & control , NF-kappa B/physiology , Signal Transduction/physiology , Tumor Suppressor Proteins/physiology , Unfolded Protein Response , Animals , Cell Cycle Checkpoints , Hepatitis B, Chronic/complications , Humans , Liver Regeneration , Mice , Mice, Inbred C57BL , Transcription Factor CHOP/physiology
5.
PLoS One ; 10(10): e0139551, 2015.
Article in English | MEDLINE | ID: mdl-26437447

ABSTRACT

Universal infantile hepatitis B virus (HBV) vaccination may lead to an increase in vaccine escape variants, which may pose a threat to the long-term success of massive vaccination. To determine the prevalence of occult infections in Korean vaccinated individuals, 87 vaccinated subjects were screened for the presence of HBV DNA using both the nested PCR protocol and the VERSANT HBV DNA 3.0 assay. The mutation patterns of variants were analyzed in full-length HBV genome sequences. Their HBsAg secretion and replication capacities were investigated using both in vitro transient transfection and in vivo hydrodynamic injection. The presence of HBV DNA was confirmed in 6 subjects (6.9%). All six variants had a common mutation type (X8Del) composed of an 8-bp deletion in the C-terminal region of the HBV X gene (HBxAg). Our in vitro and in vivo analyses using the full-length HBV genome indicated that the X8Del HBxAg variant reduced the secretion of HBsAg and HBV virions compared to the wild type. In conclusion, our data suggest that a novel mutation (X8Del) may contribute to occult HBV infection in Korean vaccinated individuals via a reduced secretion of HBsAg and virions, possibly by compromising HBxAg's transacting capacity.


Subject(s)
Hepatitis B Vaccines/immunology , Hepatitis B virus/genetics , Hepatitis B/virology , Trans-Activators/genetics , Vaccination , Adult , Alanine Transaminase/blood , Animals , Asymptomatic Diseases , Cell Line , DNA, Viral/genetics , Female , Genome, Viral , Hepatitis B/epidemiology , Hepatitis B/prevention & control , Hepatitis B/transmission , Hepatitis B Surface Antigens/blood , Hepatitis B Surface Antigens/physiology , Hepatitis B e Antigens/blood , Hepatitis B virus/isolation & purification , Humans , Male , Mice , Mice, Inbred C57BL , Middle Aged , Mutation , Phylogeny , Polymerase Chain Reaction/methods , Prevalence , Republic of Korea , Sequence Alignment , Sequence Deletion , Trans-Activators/physiology , Transfection , Viral Regulatory and Accessory Proteins , Virion , Virus Replication
6.
Vaccine ; 33(35): 4300-6, 2015 Aug 20.
Article in English | MEDLINE | ID: mdl-25862298

ABSTRACT

The phenomenon of aggregation of virus-like particles (VLPs) in salt solution and the corresponding effect upon antigenicity was reported. Asymmetrical flow field-flow fractionation (AF4) combined with multi-angle laser light scattering (MALLS) was used to characterize the size and the aggregation behavior of hepatitis B surface antigen (HBsAg). The average diameter of HBsAg VLP was 22.8±0.4 nm and it tended to aggregate in salt solution to form large particles and the antigenicity changed accordingly. In 0-4 M NaCl solution, part of HBsAg molecules aggregated rapidly into oligomeric particles (OP), whose diameter distributed from 25 to 40 nm, and the antigenicity slightly decreased about 10%. The aggregation reaction is reversible. After removing NaCl, both size and antigenicity could recover to normal level (92-96%). By contrast, the aggregation process is more complicated in (NH4)2SO4 solution. Most of HBsAg particles aggregated into OP and further aggregated into polymeric particles (PP). The diameter of the PP could reach 40 to 140 nm. The concentration of (NH4)2SO4 had remarkable influence upon the rate of aggregation. When concentration of (NH4)2SO4 was below 1 M, most of HBsAg aggregated only into OP in 1 h. While with concentration of (NH4)2SO4 above 1 M, most of particles formed PP within 1 h. The aggregation process to PP was irreversible. After removing (NH4)2SO4, the large aggregates could not recover to normal particles and the remaining antigenicity was below 30%.


Subject(s)
Hepatitis B Surface Antigens/chemistry , Hepatitis B Surface Antigens/immunology , Ammonium Compounds , Fractionation, Field Flow , Hepatitis B Surface Antigens/physiology , Microscopy, Electron, Transmission , Particle Size , Sodium Chloride
8.
J Virol ; 84(7): 3373-81, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20089655

ABSTRACT

Cyclophilin A (CypA), predominantly located intracellularly, is a multifunctional protein. We previously reported decreased CypA levels in hepatocytes of transgenic mice expressing hepatitis B virus (HBV) surface antigen (HBsAg). In this study, we found that expression of HBV small surface protein (SHBs) in human hepatoma cell lines specifically triggered CypA secretion, whereas SHBs added extracellularly to culture medium did not. Moreover, CypA secretion was not promoted by the expression of a secretion deficient SHBs mutant, suggesting a close association between secretion of CypA and SHBs. Interaction between CypA and SHBs was observed by using coimmunoprecipitation and glutathione S-transferase pull-down assays. Hydrodynamic injection of the SHBs expression construct into C57BL/6J mice resulted in increased serum CypA levels and ALT/AST levels, as well as the infiltration of inflammatory cells surrounding SHBs-positive hepatocytes. The inflammatory response and serum ALT/AST level were reduced when the chemotactic effect of CypA was inhibited by cyclosporine and anti-CD147 antibody. Furthermore, higher serum CypA levels were detected in chronic hepatitis B patients than in healthy individuals. In HBV patients who had received liver transplantation, serum CypA levels declined dramatically after the loss of HBsAg as a consequence of liver transplantation. Taken together, these results indicate that expression and secretion of SHBs can promote CypA secretion, which may contribute to the pathogenesis of HBV infection.


Subject(s)
Cyclophilin A/metabolism , Hepatitis B Surface Antigens/physiology , Hepatitis B, Chronic/etiology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Cells, Cultured , Cyclosporine/pharmacology , Humans , Mice , Mice, Inbred C57BL , Mice, Transgenic , Virus Replication
9.
J Virol ; 84(4): 1989-2000, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20007265

ABSTRACT

Previous studies showed that the N-terminal 75 amino acids of the pre-S1 domain of the hepatitis B virus (HBV) L protein are essential for HBV and hepatitis delta virus (HDV) infectivity. Consistently, synthetic lipopeptides encompassing this sequence or only parts of it efficiently block HBV and HDV infection, presumably through specific interference with a cellular receptor. Crucial for both virus infectivity and the inhibitory activity of the peptides are N-terminal myristoylation and a highly conserved motif within the N-terminal 48 amino acids. To refine the sequence requirements, we synthesized a series of HBV pre-S1 peptides containing deletions, point mutations, d-amino acid exchanges, or genotype-specific sequence permutations. Using the HepaRG cell line and a genotype D-derived virus, we determined the specific inhibitory activities of the peptides and found that (i) lipopeptides with an artificial consensus sequence inhibit HBV genotype D infection more potently than the corresponding genotype D peptides; (ii) point mutations, d-amino acid exchanges, or deletions introduced into the highly conserved part of the pre-S1 domain result in an almost complete loss of activity; and (iii) the flanking sequences comprising amino acids 2 to 8, 16 to 20, and, to a less pronounced extent, 34 to 48 gradually increase the inhibitory activity, while amino acids 21 to 33 behave indifferently. Taken together, our data suggest that HBV pre-S1-mediated receptor interference and, thus, HBV receptor recognition form a highly specific process. It requires an N-terminal acyl moiety and a highly conserved sequence that is present in primate but not rodent or avian hepadnaviruses, indicating different entry pathways for the different family members.


Subject(s)
Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/physiology , Hepatitis B virus/genetics , Hepatitis B virus/physiology , Protein Precursors/genetics , Protein Precursors/physiology , Receptors, Virus/physiology , Viral Envelope Proteins/genetics , Viral Envelope Proteins/physiology , Acylation , Amino Acid Sequence , Cell Line , Genotype , Hepatitis B Surface Antigens/chemistry , Hepatitis B virus/pathogenicity , Hepatitis Delta Virus/genetics , Hepatitis Delta Virus/pathogenicity , Hepatitis Delta Virus/physiology , Humans , Molecular Sequence Data , Protein Precursors/chemistry , Protein Structure, Tertiary , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Deletion , Viral Envelope Proteins/chemistry , Virulence/genetics , Virulence/physiology
10.
J Gen Virol ; 91(Pt 4): 1004-12, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19940060

ABSTRACT

Hepatitis B surface antigen (HBsAg) is essential for the assembly and infection of hepatitis D virus (HDV). The assembly efficiency of genotype 1 HDV is higher than that of genotype 2, whilst the P62L substitution of major HBsAg further compromises the assembly of genotype 2 and 4 HDV. This study investigated the influence of proline residues in the carboxyl end of the large hepatitis delta antigen (HDAg-L) on the assembly of HDV of different genotypes. Expression vectors containing the HDAg-L gene or full-length HDV genome of genotype 1, 2 or 4 were co-transfected with plasmids expressing HBsAg proteins that bore either proline or leucine residues at position 62. Of the eight HDV genotypes, only genotype 1 has Pro-205 in HDAg-L, whereas genotypes 2 and 4 have Arg-205. The Arg-205 to Pro-205 substitution in HDV-2 and -4 markedly increased the assembly efficiencies of HDAg-L and whole HDV genomes, even in the presence of HBsAg with Leu-62. In contrast, secretion of genotype 1 HDV or HDAg-L was reduced significantly when arginine or alanine replaced Pro-205. When HBsAg contained Pro-62, the influence of Pro-205 on assembly decreased. In conclusion, both Pro-205 of the HDAg-L and Pro-62 of the major HBsAg play critical roles in the assembly of HDV of different genotypes. The presence of Pro-205 in genotype 1 HDV may account for its higher assembly efficiencies and wider distribution.


Subject(s)
Hepatitis B Surface Antigens/physiology , Hepatitis Delta Virus/physiology , Hepatitis delta Antigens/physiology , Virus Assembly , Amino Acid Substitution , Genotype , Hepatitis B Surface Antigens/chemistry , Hepatitis Delta Virus/classification , Hepatitis Delta Virus/genetics , Hepatitis delta Antigens/chemistry , Proline , Protein Structure, Tertiary
11.
J Virol ; 83(23): 12443-51, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19759159

ABSTRACT

The hepatitis B virus (HBV) envelope proteins bear two determinants of viral entry: a receptor-binding site (RBS) in the pre-S1 domain of the large envelope protein and a conformation-dependent determinant, of unknown function, in the antigenic loop (AGL) of the small, middle, and large envelope proteins. Using an in vitro infection assay consisting of susceptible HepaRG cells and the hepatitis delta virus (HDV) as a surrogate of HBV, we first investigated whether subelements of the pre-S1 determinant (amino acids 2 to 75), i.e., the N-terminal myristoyl anchor, subdomain 2-48 (RBS), and subdomain 49-75, were functionally separable. In transcomplementation experiments, coexpression of two distinct infectivity-deficient pre-S1 mutants at the surface of HDV virions failed to restore infectivity, indicating that the myristoyl anchor, the 2-48 RBS, and the 49-75 sequence, likely cooperate in cis at viral entry. Furthermore, we showed that as much as 52% of total pre-S1 in the HDV envelope could bear infectivity-deficient lesions without affecting entry, indicating that a small number of pre-S1 polypeptides-estimated at three to four per virion-is sufficient for infectivity. We next investigated the AGL activity in the small or large envelope protein background (S- and L-AGL, respectively) and found that lesions in S-AGL were more deleterious to infectivity than in L-AGL, a difference that reflects the relative stoichiometry of the small and large envelope proteins in the viral envelope. Finally, we showed that C147S, an AGL infectivity-deficient substitution, exerted a dominant-negative effect on infectivity, likely reflecting an involvement of C147 in intermolecular disulfide bonds.


Subject(s)
Hepatitis B Surface Antigens/physiology , Hepatitis B virus/physiology , Protein Precursors/physiology , Viral Envelope Proteins/physiology , Virus Internalization , Cell Line , Hepatitis B Surface Antigens/genetics , Hepatitis Delta Virus/genetics , Humans , Models, Biological , Mutation, Missense , Protein Precursors/genetics , Sequence Deletion , Viral Envelope Proteins/genetics
12.
J Virol ; 83(22): 11819-29, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19740987

ABSTRACT

The early steps of the hepatitis B virus (HBV) life cycle are still poorly understood. Indeed, neither the virus receptor at the cell surface nor the mechanism by which nucleocapsids are delivered to the cytosol of infected cells has been identified. Extensive mutagenesis studies in pre-S1, pre-S2, and most of the S domain of envelope proteins revealed the presence of two regions essential for HBV infectivity: the 77 first residues of the pre-S1 domain and a conformational motif in the antigenic loop of the S domain. In addition, at the N-terminal extremity of the S domain, a putative fusion peptide, partially overlapping the first transmembrane (TM1) domain and preceded by a PEST sequence likely containing several proteolytic cleavage sites, was identified. Since no mutational analysis of these two motifs potentially implicated in the fusion process was performed, we decided to investigate the ability of viruses bearing contiguous deletions or substitutions in the putative fusion peptide and PEST sequence to infect HepaRG cells. By introducing the mutations either in the L and M proteins or in the S protein, we demonstrated the following: (i) that in the TM1 domain of the L protein, three hydrophobic clusters of four residues were necessary for infectivity; (ii) that the same clusters were critical for S protein expression; and, finally, (iii) that the PEST sequence was dispensable for both assembly and infection processes.


Subject(s)
Hepatitis B virus/physiology , Viral Envelope Proteins/physiology , Cell Line, Tumor , Hepatitis B/virology , Hepatitis B Surface Antigens/physiology , Hepatitis B e Antigens/physiology , Humans , Mutagenesis, Site-Directed
13.
Gut ; 58(11): 1528-37, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19651630

ABSTRACT

BACKGROUNDS AND AIMS: Telomerase is significantly reactivated in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). Our previous studies showed that the transactivation unit of HBV surface (S) gene, preS2, could upregulate human telomerase reverse transcriptase (hTERT) expression and telomerase activity of HepG2 cells. Here, we aim to explore the functions, and the underlying mechanisms, of this preS2-mediated hTERT upregulation during HCC development. METHODS: An antisense blocking assay was performed on HBV-integrated HepG2.2.15 cells. The expression of hTERT was examined in clinical samples to test the role of the preS2-mediated hTERT upregulation in HCC development in vivo. In order to explore the mechanisms of preS2-mediated hTERT upregulation, co-transfection, reporter assays and electrophoretic mobility shift assays (EMSA) were performed. RESULTS: Blocking preS2 expression reduced hTERT expression, telomerase activity, cell proliferation and tumorigenicity of HepG2.2.15. A region located between -349 and -329 bp upstream of the transcription initiation site of hTERT was identified as responsible for the preS2-mediated effect. preS2 interacted with the preS2-responsible region (PRR) and activated the hTERT promoter. Importantly, hTERT was also highly expressed in preS2-positive human HCC samples. All these findings strongly suggest that preS2 may promote HCC development via hTERT activation. CONCLUSIONS: HBV protein preS2 upregulates hTERT via the PRR element in promoting HCC development.


Subject(s)
Carcinoma, Hepatocellular/etiology , Hepatitis B Surface Antigens/physiology , Liver Neoplasms/etiology , Protein Precursors/physiology , Telomerase/metabolism , Transcription, Genetic , Adult , Aged , Animals , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/virology , Cell Line, Tumor , Cell Proliferation , Enzyme Activation , Female , Gene Expression Regulation, Neoplastic , Hep G2 Cells , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Liver Neoplasms/virology , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Middle Aged , Protein Precursors/antagonists & inhibitors , RNA, Antisense/metabolism , Telomerase/genetics , Up-Regulation
14.
Hum Reprod ; 24(7): 1575-83, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19279032

ABSTRACT

BACKGROUND: Hepatitis B virus (HBV) has been determined to exist in semen and male germ cells from patients with chronic HBV infection, but no data are yet available on the impact of HBV S protein (HBs), the main component of HBV envelop protein, on the human reproductive system. The purpose of this article was to investigate the effect of HBs on human sperm function. METHODS: Sperm motility analyses, sperm penetration assays, mitochondrial membrane potential assays, immunolocalizations with confocal microscopy and flow cytometry analyses were performed. RESULTS: HBs reduced sperm motility in a dose- and time-dependent manner and caused the loss of sperm mitochondrial membrane potential. HBs-HBs monoclonal antibody (MAb) complex apparently aggravated such impairments. After 4 h incubation with HBs at concentrations of 25, 50, 100 microg/ml, the percentages of sperm motility a+b significantly decreased compared with the control (P < 0.01). The fertilization rate and the fertilizing index in HBs-treated group were 40% and 0.57, respectively, which were significantly lower than 90% and 1.6, respectively, in the control (P < 0.01). The asialoglycoprotein receptor (ASGP-R) and HBs were found to localize mainly on the postacrosomal region. Both ASGP-R MAb and asialofoetuin, a high-affinity ligand of ASGP-R, inhibited the HBs-caused loss of sperm motility and mitochondrial membrane potential. CONCLUSIONS: HBs had adverse effects on human sperm function, and ASGP-R may play a role in the uptake of HBs into sperm cells, as demonstrated by the competitive inhibition of ASGP-R MAb or asialofoetuin, resulting in diminished impairment caused by HBs.


Subject(s)
Hepatitis B Surface Antigens/physiology , Hepatitis B virus/metabolism , Hepatitis B/metabolism , Spermatozoa/metabolism , Antibodies, Monoclonal/chemistry , Asialoglycoprotein Receptor/metabolism , Asialoglycoproteins/metabolism , Dose-Response Relationship, Drug , Fertilization , Fetuins , Hepatitis B Surface Antigens/metabolism , Humans , Ligands , Male , Membrane Potentials , Mitochondria/metabolism , Spermatozoa/virology , Time Factors , alpha-Fetoproteins/metabolism
15.
Anim Biotechnol ; 19(2): 104-16, 2008.
Article in English | MEDLINE | ID: mdl-18432401

ABSTRACT

Somatostatin (SS) and growth hormone-releasing hormone (GHRH) are synthesized and secreted by the hypothalamus, which can control the synthesis and secretion of the growth hormone (GH) from the hypophysis as well as regulate the GH concentrations in animals and humans. In this article, we describe the regulation of animal growth using plasmid DNA encoding both the GHRH gene and the SS gene fused with the hepatitis B surface antigen (HBsAg) gene. We constructed a series of expression plasmids to express the GHRH and HBsAg-SS fusion genes individually as well as collectively. The fusion gene and GHRH were successfully expressed in Chinese hamster ovary (CHO) cells, as proven by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunoblotting tests. Poly D, L-lactide-co-glycolic acid (PLGA) plasmid-encapsulating microspheres were prepared and injected intramuscularly into the leg skeletal muscles of rabbits. Weight gain/day and the levels of insulinlike growth factor-I (IGF-I), SS, and hepatitis B surface antibody (HBsAb) were monitored. During days 30 postinjection, increase in weight gain/day and IGF- I concentration and decrease in SS were observed in treatment groups. From days 15 to 30 postinjection, the weight gain/day significantly increased (P < 0.05) by 129.13%, 106.8%, and 72.82% relative to the control group in the co-expression GHRH and fusion gene (named P-G-HS), fusion gene (named P-HS), and GHRH (named P-G) groups, respectively. And most importantly, the P-G-HS group showed significant weight gain/day (P < 0.05) relative to the P-G and P-HS groups. A significant increase in the IGF-I concentration and decrease in the SS level relative to the control group were also observed. The results indicated that the combination of plasmid-mediated GHRH supplementation and positive immunization against SS led to more robust weight gain/day in rabbits.


Subject(s)
Gonadotropin-Releasing Hormone/physiology , Hepatitis B Surface Antigens/physiology , Muscle, Skeletal/physiology , Rabbits/growth & development , Somatostatin/physiology , Animals , Body Weight/drug effects , Body Weight/physiology , CHO Cells , Cloning, Molecular , Cricetinae , Cricetulus , DNA/chemistry , DNA/genetics , Gene Fusion , Gonadotropin-Releasing Hormone/biosynthesis , Gonadotropin-Releasing Hormone/genetics , Hepatitis B Surface Antigens/biosynthesis , Hepatitis B Surface Antigens/genetics , Insulin-Like Growth Factor I/metabolism , Lactic Acid/administration & dosage , Male , Microspheres , Plasmids/genetics , Polyglycolic Acid/administration & dosage , Polylactic Acid-Polyglycolic Acid Copolymer , Polymerase Chain Reaction , Rabbits/physiology , Somatostatin/biosynthesis , Somatostatin/genetics , Transfection/veterinary
16.
J Pept Sci ; 14(3): 307-12, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17918766

ABSTRACT

As a hepatitis B virus (HBV) envelope domain, preS plays significant roles in receptor recognition and viral infection. However, the regions critical for maintaining a stable and functional conformation of preS are still unclear and require further investigation. In order to unravel these regions, serially truncated fragments of preS were constructed and expressed in Escherichia coli. Their solubility, stability, secondary structure, and affinity to polyclonal antibodies and hepatocytes were examined. The results showed that amino acids 31-36 were vital for its stable conformation, and the absence of 10-36 amino acids significantly reduced its binding to polyclonal antibodies as well as hepatocytes. The most stable fragment 1-120 (preS1 + N-terminal 12 amino acids of preS2), perhaps the core of preS, was discovered, which bound to HepG2 cells most tightly. Moreover, the availability of large amounts of well-folded and stable preS1-120 enables us to carry out further structural determination and mechanistic study on HBV infection.


Subject(s)
Hepatitis B virus/physiology , Protein Precursors/physiology , Viral Envelope Proteins/physiology , Amino Acid Motifs , Hepatitis B Surface Antigens/chemistry , Hepatitis B Surface Antigens/physiology , Viral Envelope Proteins/chemistry
17.
World J Gastroenterol ; 13(10): 1602-7, 2007 Mar 14.
Article in English | MEDLINE | ID: mdl-17461456

ABSTRACT

AIM: To clone and identify human genes transactivated by PS1TP5 by constructing a cDNA subtractive library with suppression subtractive hybridization (SSH) technique. METHODS: SSH and bioinformatics techniques were used for screening and cloning of the target genes transactivated by PS1TP5 protein. The mRNA was isolated from HepG2 cells transfected with pcDNA3.1(-)-myc-his(A)-PS1TP5 and pcDNA3.1(-)-myc-his(A) empty vector, respectively, and SSH technique was employed to analyze the differentially expressed DNA sequence between the two groups. After digestion with restriction enzyme Rsa I, small size cDNAs were obtained. Then tester cDNA was divided into two groups and ligated to the specific adaptor 1 and adaptor 2, respectively. The tester cDNA was hybridized with driver cDNA twice and subjected to nested PCR for two times, and then subcloned into T/A plasmid vectors to set up the subtractive library. Amplification of the library was carried out with E. coli strain DH5alpha. The cDNA was sequenced and analyzed in GenBank with Vector NTI 9.1 and NCBI BLAST software after PCR amplification. RESULTS: The subtractive library of genes transactivated by PS1TP5 was constructed successfully. The amplified library contained 90 positive clones. Colony PCR showed that 70 clones contained 200-1000-bp inserts. Sequence analysis was performed in 30 clones randomly, and the full-length sequences were obtained by bioinformatics technique. Altogether 24 coding sequences were obtained, which consisted of 23 known and 1 unknown. One novel gene with unknown functions was found and named as PS1TP5TP1 after being electronically spliced, and deposited in GenBank (accession number: DQ487761). CONCLUSION: PS1TP5 is closely correlated with immunoregulation, carbohydrate metabolism, signal transduction, formation mechanism of hepatic fibrosis, and occurrence and development of tumor. Understanding PS1TP5 transactive proteins may help to bring some new clues for further studying the biological functions of pre-S1 protein.


Subject(s)
Cloning, Molecular/methods , Hepatitis B Surface Antigens/physiology , Hepatitis B virus/genetics , Hepatitis B virus/physiology , Protein Precursors/physiology , Proteins/genetics , Transcriptional Activation , Amino Acid Sequence , Base Sequence , Cell Line, Tumor , DNA, Viral/genetics , Gene Library , Genetic Vectors/genetics , Hepatoblastoma/genetics , Hepatoblastoma/physiopathology , Humans , Liver Neoplasms/genetics , Liver Neoplasms/physiopathology , Molecular Sequence Data , Nucleic Acid Hybridization , Proteins/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism
18.
J Virol ; 81(11): 5841-9, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17376925

ABSTRACT

The N-terminal pre-S domain of the large hepatitis B virus (HBV) envelope protein plays a pivotal role at the initial step of the viral entry pathway. In the present study, the entire pre-S domain was mapped for infectivity determinants, following a reverse-genetics approach and using in vitro infection assays with hepatitis delta virus (HDV) or HBV particles. The results demonstrate that lesions created within the N-terminal 75 amino acids of the pre-S region abrogate infectivity, whereas mutations between amino acids 76 and 113, overlapping the matrix domain, had no effect. In contrast to the results of a recent study (L. Stoeckl, A. Funk, A. Kopitzki, B. Brandenburg, S. Oess, H. Will, H. Sirma, and E. Hildt, Proc. Natl. Acad. Sci. 103:6730-6734, 2006), the deletion of a cell membrane translocation motif (TLM) located between amino acids 148 and 161 at the C terminus of pre-S2 did not interfere with the infectivity of the resulting HDV or HBV mutants. Furthermore, a series of large deletions overlapping the pre-S2 domain were compatible with infectivity, although the efficiency of infection was reduced when the deletions extended to the pre-S1 domain. Overall, the results demonstrate that the activity of the pre-S domain at viral entry solely depends on the integrity of its first 75 amino acids and thus excludes any function of the matrix domain or TLM.


Subject(s)
Amino Acids/chemistry , Amino Acids/physiology , Hepatitis B Surface Antigens/chemistry , Hepatitis B Surface Antigens/physiology , Hepatitis B virus/chemistry , Hepatitis B virus/pathogenicity , Protein Precursors/chemistry , Protein Precursors/physiology , Amino Acid Motifs/genetics , Amino Acid Sequence , Amino Acids/genetics , Cell Line, Tumor , Hepatitis B/metabolism , Hepatitis B/virology , Hepatitis B Surface Antigens/genetics , Hepatitis B virus/genetics , Hepatitis Delta Virus/chemistry , Hepatitis Delta Virus/genetics , Hepatitis Delta Virus/pathogenicity , Humans , Molecular Sequence Data , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/physiology , Protein Precursors/genetics , Protein Structure, Tertiary/genetics , Protein Transport/genetics , Sequence Deletion/genetics , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Envelope Proteins/physiology
19.
World J Gastroenterol ; 13(1): 22-38, 2007 Jan 07.
Article in English | MEDLINE | ID: mdl-17206752

ABSTRACT

Hepadnaviridae is a family of hepatotropic DNA viruses that is divided into the genera orthohepadnavirus of mammals and avihepadnavirus of birds. All members of this family can cause acute and chronic hepatic infection, which in the case of human hepatitis B virus (HBV) constitutes a major global health problem. Although our knowledge about the molecular biology of these highly liver-specific viruses has profoundly increased in the last two decades, the mechanisms of attachment and productive entrance into the differentiated host hepatocytes are still enigmatic. The difficulties in studying hepadnaviral entry were primarily caused by the lack of easily accessible in vitro infection systems. Thus, for more than twenty years, differentiated primary hepatocytes from the respective species were the only in vitro models for both orthohepadnaviruses (e.g. HBV) and avihepadnaviruses (e.g. duck hepatitis B virus [DHBV]). Two important discoveries have been made recently regarding HBV: (1) primary hepatocytes from tree-shrews; i.e., Tupaia belangeri, can be substituted for primary human hepatocytes, and (2) a human hepatoma cell line (HepaRG) was established that gains susceptibility for HBV infection upon induction of differentiation in vitro. A number of potential HBV receptor candidates have been described in the past, but none of them have been confirmed to function as a receptor. For DHBV and probably all other avian hepadnaviruses, carboxypeptidase D (CPD) has been shown to be indispensable for infection, although the exact role of this molecule is still under debate. While still restricted to the use of primary duck hepatocytes (PDH), investigations performed with DHBV provided important general concepts on the first steps of hepadnaviral infection. However, with emerging data obtained from the new HBV infection systems, the hope that DHBV utilizes the same mechanism as HBV only partially held true. Nevertheless, both HBV and DHBV in vitro infection systems will help to: (1) functionally dissect the hepadnaviral entry pathways, (2) perform reverse genetics (e.g. test the fitness of escape mutants), (3) titrate and map neutralizing antibodies, (4) improve current vaccines to combat acute and chronic infections of hepatitis B, and (5) develop entry inhibitors for future clinical applications.


Subject(s)
Hepadnaviridae Infections/etiology , Hepadnaviridae Infections/pathology , Hepadnaviridae/pathogenicity , Virus Internalization , Animals , Cell Line , Ducks , Hepadnaviridae/genetics , Hepadnaviridae/physiology , Hepadnaviridae Infections/genetics , Hepadnaviridae Infections/physiopathology , Hepatitis B Surface Antigens/physiology , Hepatitis B Virus, Duck/genetics , Hepatitis B Virus, Duck/pathogenicity , Hepatitis B Virus, Duck/physiology , Hepatocytes/pathology , Hepatocytes/virology , Humans , Protein Precursors/physiology , Tupaia , Viral Envelope Proteins/physiology , Virion/genetics , Virion/pathogenicity , Virion/physiology , Virus Replication/physiology
20.
World J Gastroenterol ; 13(1): 74-81, 2007 Jan 07.
Article in English | MEDLINE | ID: mdl-17206756

ABSTRACT

Hepatocellular carcinoma (HCC) is one of the most common cancers in the world with an annual incidence of more than 500000 in the year 2000. Its incidence is rising in many countries. Recently, it has been estimated that about 53% of HCC cases in the world are related to hepatitis B virus (HBV). The epidemiological association of HBV with HCC is well established. In recent studies, it was revealed that HBsAg carriers have a 25-37 times increased risk of developing HCC as compared to non-infected people. At present, HBV-associated carcinogenesis can be seen as a multi-factorial process that includes both direct and indirect mechanisms that might act synergistically. The integration of HBV DNA into the host genome occurs at early steps of clonal tumor expansion. The integration has been shown in a number of cases to affect a variety of cancer-related genes and to exert insertional mutagenesis. The permanent liver inflammation, induced by the immune response, resulting in a degeneration and regeneration process confers to the accumulation of critical mutations in the host genome. In addition to this, the regulatory proteins HBx and the PreS2 activators that can be encoded by the integrate exert a tumor promoter-like function resulting in positive selection of cells producing a functional regulatory protein. Gene expression profiling and proteomic techniques may help to characterize the molecular mechanisms driving HBV-associated carcinogenesis, and thus potentially identify new strategies in diagnosis and therapy.


Subject(s)
Carcinoma, Hepatocellular/virology , Hepatitis B virus/physiology , Liver Neoplasms/virology , Oncogenic Viruses/physiology , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/pathology , Cell Transformation, Neoplastic/pathology , DNA, Viral/genetics , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Gene Expression Regulation, Viral , Hepatitis B/complications , Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/physiology , Hepatitis B virus/genetics , Humans , Liver Neoplasms/etiology , Liver Neoplasms/pathology , Mutation/genetics , Oncogenic Viruses/genetics , Protein Precursors/genetics , Protein Precursors/physiology , Risk Factors , Trans-Activators , Viral Regulatory and Accessory Proteins/genetics , Viral Regulatory and Accessory Proteins/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...